23 LifeScience Companies Changing the World : BioPharma APAC 2023 Outlook

03 January 2023 | Tuesday | News


The Outlook for 2023 and Beyond 23 giants from the world of biotech and life sciences offer their vision for the future of the industry over the next decade.
Image Source : Public Domain

Image Source : Public Domain

These companies are often involved in the research, development, and production of pharmaceuticals, medical devices, and other health-related products. 

 

  1. Roche - $64.3 billion
  2. Johnson & Johnson - $82.1 billion
  3. Pfizer - $53.7 billion
  4. Novartis - $47.5 billion
  5. Merck & Co. - $45.8 billion
  6. AstraZeneca - $26.8 billion
  7. Sanofi - $40.8 billion
  8. GlaxoSmithKline - $43.7 billion
  9. AbbVie - $45.6 billion
  10. Amgen - $23.4 billion
  11. Bristol-Myers Squibb - $26.8 billion
  12. Eli Lilly and Company - $22.4 billion
  13. Takeda Pharmaceutical - $17.9 billion
  14. Teva Pharmaceutical Industries - $16.2 billion
  15. Thermo Fisher Scientific - $25.3 billion
  16. Biogen - $11.4 billion
  17. Celgene - $11.4 billion
  18. Gilead Sciences - $22.2 billion
  19. Regeneron Pharmaceuticals - $7.1 billion
  20. Vertex Pharmaceuticals - $6.0 billion
  21. Astellas Pharma - $17.1 billion
  22. Boehringer Ingelheim - $17.8 billion
  23. Merck KGaA - $16.1 billion

Please note that these figures are from 2021 and may not reflect the current revenue of these companies. Additionally, the rankings may vary depending on the source and the criteria used to evaluate the companies.

 
 
 

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close